Extract
Tuberculosis (TB) remains one of the world's deadliest infectious diseases. The World Health Organization (WHO) estimated that, in 2014 alone, 9.6 million people fell ill with TB and 1.5 million died due to the disease [1]. South-East Asia and Western Pacific Regions accounted for 58% of these [1]. As most deaths from TB can now be prevented, efforts must be accelerated to ensure the targets of the Sustainable Development Goals are reached [1].
Abstract
Fixed-dose combination and therapeutic drug monitoring can be combined in programmatic treatment of tuberculosis http://ow.ly/sCtd302h0Ka
Footnotes
Conflict of interest: None declared.
- Received April 27, 2016.
- Accepted July 6, 2016.
- Copyright ©ERS 2016